ShareValue scores for 2581.HK: Valuation 68, Quality 50, Growth 50, Health 65.

2581.HK
HKEX

BenQ BM Holding Cayman Corp.

HK$2.90(+0.69%)

Updated

Loading chart...
Sentiment

Pulse

Rating

Moderate

Trap Risk

P/E to median

Not enough data
Valuation
68
Fair Value

vs Hong Kong-listed Healthcare stocks

Price vs Value
Quality
50
Moderate
Business Strength
Growth
50
Moderate
Revenue & Earnings
Health
65
Moderate
Financial Stability
Price trend
81
Strong
Separate from the four scores

Company Details

About

BenQ BM Holding Cayman Corp., through its subsidiaries, owns and operates hospitals in the People's Republic of China. It operates two general hospitals, namely Nanjing BenQ Hospital and Suzhou BenQ Hospital. The company provides medical services, including disease diagnosis and treatment, health management, and medical support; outpatient, inpatient, surgical, and related medical support services; ancillary medical services, such as laboratory testing, imaging, nursing, and other supporting services; emergency medical services; and thoracic surgery, nephrology, neurosurgery, obstetrics, critical care medicine, etc. It also offers management and healthcare services. In addition, the company provides services in the field of otolaryngology, head, and neck surgery; neurology; orthopedics; hemodialysis; gynecology and pediatrics; heart; urinary surgery; rehabilitation; galactophore; intestinal fistula and abdominal infection; and medical imaging. The company was incorporated in 2009 and is headquartered in Nanjing, China.

Score Analysis

AI Investment Thesis

Powered by DeepSeek. For research only. Not financial advice.

Sources:[1][2][3][4]

BenQ BM Holding Cayman Corp. is fairly valued: its P/E of 11.7 is lower than 57% of Hong Kong-listed Healthcare peers, while P/B of 0.33 is lower than 92% and P/S of 0.32 lower than 86%.

Data as of:Nov 6, 2026

By using ShareValue.ai you agree to our Terms and Privacy Policy. Educational platform, not investment advice.